JGJianping Gu

Jianping Gu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jianping Gu has a total of 197 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of computed tomography-imaged common iliac vein compression with inferior vena cava thrombosis: a propensity score-matched analysis

    by Maofeng Gong, Rui Jiang, Jie Kong, Zhengli Liu, Boxiang Zhao, Xu He, Jianping Gu, Zhengcan Wu

    Background: Investigating the association between common iliac vein (CIV) compression and inferior vena cava (IVC) thrombosis could have important clinical implications, such as a potential reduction in the use of IVC filters in low-risk patients and guidance for decision-making in thrombosis management. This study aimed to clarify the impact of the CIV compression degree on the incidence of IVC thrombosis in patients with lower extremity deep vein thrombosis (DVT). Methods: This single-center, retrospective study was performed between January 2015 and July 2023. A total of 391 eligible patients (mean age 60.42±16.67 years; 53.96% male) were included. The quantitative evaluation included the minimum diameter of the CIV, and the compression percentage was calculated on computed tomography venography. Univariable analysis and subsequent multivariable analysis, as well as propensity score matching (PSM), were used to analyze odds ratios (ORs) with 95% confidence intervals (CIs). The association between IVC thrombosis and CIV compression on a continuous scale was evaluated via restricted cubic splines (RCSs). Results: Iliofemoral DVT and a larger minimum diameter were associated with an increased risk of IVC thrombosis, whereas older age and a higher compression percentage were linked to a decreased risk. After adjustments for age, male sex, hypertension, and iliofemoral DVT via PSM, the statistically significant associations of CIV minimum diameter (adjusted OR =1.10, 95% CI: 1.02–1.18; PConclusions: Compared with no or mild compression, moderate and severe CIV compression was associated with a reduced risk of IVC thrombosis. A higher CIV compression degree was consistently associated with a decreased IVC thrombosis risk when the minimum diameter was 49.81%.

  • Relationship Between Left Moderate or Severe Common Iliac Vein Compression and Occurrence of Involved Iliac Vein Thrombosis in Patients with Infrainguinal Deep Vein Thrombosis

    by Maofeng Gong, Rui Jiang, Xu He, Zhengcan Wu, Jianping Gu

    Purpose To investigate the association between the degree of common iliac vein (CIV) compression and the incidence of iliac vein involvement thrombosis (IVT) in patients with infrainguinal deep vein thrombosis (DVT). Methods This was a single center retrospective study. Between January 2015 and July 2023, infrainguinal DVT patients with or without IVT were included. Patient baseline demographics, clinical characteristics, and radiographic variables were collected and analyzed. Univariate analysis followed by multivariate analysis was used for IVT to determine odds ratio (OR) with a 95% confidence interval (CI). The association of the degree of CIV compression and IVT was evaluated by restricted cubic spines (RCS) on a continuous scale. Results 222 left-sided DVT patients [140 (63.1%) patients diagnosed with IVT, and 82 (36.9%) without] were included. Univariate analyses revealed a higher prevalence of female gender (55.7 vs. 41.5%, p = .040) and CIV compression among patients with left-sided IVT compared to those without IVT. After adjusting for female gender, a strong positive association between IVT and moderate (compression degree > 50% and ≤ 75%) (adjusted OR 3.75; 95% CI 1.571–8.974; p = .003) to severe (> 75%) (adjusted OR 4.05; 95% CI 1.615–10.134; p = .003) CIV compression degrees remained, indicating moderate or severe compression significantly increased IVT risk. RCS showed that a greater CIV minimum diameter or a smaller compression percentage was negatively associated with IVT incidence at a CIV minimum diameter was > 4.1 mm (p < .001) or compression percentage was < 61.0% (p < .001). Conclusion Moderate and severe CIV compression were associated with increased IVT risk compared to no or mild compression. A decreasing degree of CIV compression was consistently associated with a decreasing risk of IVT when the minimum diameter was > 4.1 mm or the compression was < 61.0%. Graphical Abstract


  • Open Access

    Efficacy and safety of a novel vena cava filter on pulmonary embolism prophylaxis: a prospective, multicenter, randomized, parallel, positive-controlled, noninferiority clinical trial

    by Maofeng Gong, Boxiang Zhao, Jianlong Liu, Gaojun Teng, Caifang Ni, Hao Xu, Zhen Li, Shuiting Zhai, Yanrong Zhang, Hua Xiang, et al.

    Background: There are different types of vena cava filter (VCF) available in clinical practice. However, limited data exist to determine whether one type is superior to another, and no single VCF is universally recommended in clinical guidelines. The objective of this study was to investigate the safety and efficacy of a novel VCF, Octoparms, for the prevention of pulmonary embolism (PE) and to compare it with the Celect filter. Methods: This multicenter, randomized, open-label, parallel, positive-controlled, noninferiority trial was conducted in 10 centers across 6 provinces in China from October 2017 to March 2019. Patients who had confirmed lower extremity deep vein thrombosis or PE or who were at risk of PE with a clinical indication for VCF placement due to contraindication to or failure of anticoagulant therapy were included in the trial. The sample size for this trial was based on the assumption that the clinical success rate would be 95% and the noninferiority margin would be 10% for both filters. Each patient underwent baseline testing and was randomized using a web-based central system. Any additional interventions or standard treatments patients received along with the VCF placement were recorded. The primary endpoint was the overall clinical success rate, including technical and clinical success of filter placement and retrieval. The secondary endpoint was the safety of filter placement and retrieval, encompassing procedure-related and filter-related complications. Results: A total of 188 patients were included and were divided into two groups: the Octoparms group (n=94) and the Celect group (n=94). Baseline characteristics and demographics were comparable between the two groups (P>0.05). Technical and clinical success rates for filter placement were achieved in 100% (188/188) of patients. The median dwelling time was 12.0 days (range, 4–190 days). Ten VCFs were left in situ as permanent devices. Of the remaining 178 patients, technical success and clinical success rates for filter retrieval were both achieved in 100% of cases (178/178). Clinical success rates were 92.6% (87/94) for the Octoparms group and 96.8% (91/94) for the Celect group, with a difference of −4.2% (hazard ratio 2.441, 95% confidence interval 0.612–9.741; P=0.206). The lower limit was greater than the noninferiority margin of −10%. Eight patients experienced a total of eight procedure-related complications. No filter-related complications, such as migration, deformation, inferior vena cava (IVC) penetration, peripheral organ damage, or IVC stenosis/occlusion, were observed (P>0.05). Conclusions: The Octoparms filter exhibited a high rate of clinical success and a low rate of complications during placement and retrieval, demonstrating noninferiority to the Celect filter.


  • Unveiling the Link: Minimum Inferior Vena Cava Diameter and Thrombosis Risk

    by Maofeng Gong, Cheng Qian, Rui Jiang, Xu He, Jianping Gu


  • Open Access

    AngioJet rheolytic thrombectomy coupled with dose-reduced rt-PA for massive inferior vena cava filter-related thrombosis: A single-center retrospective study

    by Maofeng Gong, Qing Zhao, Rui Jiang, Zhengli Liu, Boxiang Zhao, Jie Kong, Xu He, Jianping Gu


  • Diagnosis and treatment of venous thromboembolism and clinical application of inferior vena cava filter in China

    by Fuxian Zhang, Jianping Gu, Xuan Li, Dong-Hua Ji, Jian Hua Huang, Jinhui Ding, Ji-Chun Zhao, Yu-Kui Ma, Yu Zhao, Mingyi Zhang, et al.


  • Open Access

    How to create a nervous system aneurysm model in canines? ligation of the lingual artery is a simple and effective method

    by Zhengli Liu, Yuan Yuan, Rui Jiang, Boxiang Zhao, Jianping Gu&Ast, Xu He, Tao Wang, Yadong Shi, Yinghao Li, Yangyi Zhou, et al.

    Background: The purpose of this research was to establish a safe, effective, and simple nervous system aneurysm model. This method could quickly and stably establish an exact canine tongue aneurysm model. This paper summarizes the technique and key points of the method.Methods: Under the condition of anesthesia by inhaling isoflurane with a mask, we punctured the femoral artery of the canine, and the tip of the catheter was placed in the common carotid artery for intracranial arteriography. The positions of the lingual artery, external carotid artery, and internal carotid artery were identified. Then, the skin near the mandible was cut according to the positioning and separated layer by layer until the bifurcation of the lingual artery and external carotid artery was exposed. The lingual artery were then sutured with 2–0 silk sutures approximately 3 mm from the external carotid/lingual artery bifurcation. The final angiographic review showed that the aneurysm model was successfully established.Results: The lingual artery aneurysm was successfully established in all 8 canines. All canines obtained a stable model of nervous system aneurysm and confirmed by DSA angiography.Conclusion: We have established a safe, effective, stable and simple method to establish a canine nervous system aneurysm model with controllable size. In addition, this method has the advantages of no arteriotomy, less trauma, constant anatomical location, and low risk of stroke.


  • Angiojet pharmacomechanical thrombectomy versus anticoagulant therapy alone in massive cancer-associated thrombosis: a single centre retrospective cohort study

    by Maofeng Gong, Guanqi Fu, Zhengli Liu, Boxiang Zhao, Jie Kong, Xu He, Jianping Gu

    The therapeutic regimen option for the cancer-associated thrombosis (CAT) patients is still a major clinical challenge. The present study aimed to investigate the safety and efficacy of pharmacomechanical catheter-directed thrombolysis (PCDT) with AngioJet treatment compared with the conventional anticoagulation alone therapy in the patients with CAT. We retrospectively reviewed the patients who underwent PCDT and/or anticoagulation for the treatment of CAT between August 1, 2016 and March 1, 2022. Each patient was divided into the PCDT group or the anticoagulation alone group. The baseline demographics, comorbidities, clinical characteristics, treatment details, course data were reviewed. A total of 51 eligible patients were included, of whom 21 were in PCDT group (mean age, 60.1 ± 13.0 years; 52.4% male) and 30 in anticoagulation alone group (mean age, 66.6 ± 11.1 years; 50.0% male). No significant differences regarding age, sex, onset time, limb characteristics, cancer conditions or risk factors were detected (p > .05). After PCDT, grade III lysis was achieved in 8 and grade II lysis in 11 patients. Clinical success was achieved in 90.5% (19/21) patients. The symptoms of leg pain and swelling were significantly improved in both groups. Except for transient macroscopic hemoglobinuria occurring in PCDT group, none of all patients suffered from procedure-related and major complications. Minor complications such as bleeding events occurred in 23.8% (5/21) of patients in PCDT group compared with 10.0% (3/30) in anticoagulation alone group (p > .05). At the 6-month follow-up, iliofemoral patency was found an absolute risk reduction of 37.9% (70.0 vs. 32.1%) (95% CI: 1.183–4.008%; P = 0.010). The incidence of mild PTS was 5.0% (1/20) in PCDT group compared with 10.7% (3/28) in anticoagulation alone group (p > .05). The PCDT is a safe and effective modality in managing patients with CAT, leading to improved clinical outcomes with a low complication. The PCDT was more effective than anticoagulation alone in massive symptom relief and venous patency.


  • Open Access

    Risk factors and a predictive model for nonfilter-associated inferior vena cava thrombosis in patients with lower extremity deep vein thrombosis

    by Maofeng Gong, Jie Kong, Yadong Shi, Boxiang Zhao, Zhengli Liu, Xu He, Jianping Gu

    Objective: Nonfilter-associated inferior vena cava thrombosis (IVCT) is an under-recognized but severe state of venous thromboembolism. The aims of this study were to investigate risk factors and develop a prediction model based on clinical data and imaging findings to evaluate the probability of IVCT in patients with lower extremity deep vein thrombosis (LEDVT).Methods: A single-center retrospective cohort study was conducted. We analyzed the clinical data and multimodal imaging findings of consecutive patients with confirmed LEDVT between February 2016 and January 2022. The demographics, presentation of LEDVT, laboratory examination, thrombus characteristics, comorbidities and risk factors for LEDVT, and imaging findings were analyzed using an independent t-test, Chi-square test, Fisher's exact test, and regression analysis to determine the univariable and multivariable associations and to establish a predictive model to assess the probability of IVCT.Results: A total of 267 eligible patients were included, of whom 40 were in the IVCT group and 227 were in the non-IVCT group. The incidence of nonfilter-associated IVCT was 15.0% (40/267). Age < 63.5 years [odds ratio (OR) 2.54; 95% confidence interval (CI), 1.10–5.85, p = 0.029], male sex (OR 2.82; 95% CI, 1.19–6.72, p = 0.019), proximal DVT (OR 8.21; 95% CI, 1.01–66.76, p = 0.049), bilateral DVT (OR 7.30; 95% CI, 3.28–16.21, p < 0.001), and D-dimer >4.72 μg/ml (OR 4.64; 95% CI, 1.80–11.72, p = 0.001) were risk factors for IVCT's occurrence. Then, we established a prediction model based on these risk factors. The diagnostic efficiency [area under the curve (AUC) of receiver operating characteristic (ROC) curve was 0.858] for predicting IVCT was superior to that of isolated risk factors, including age < 63.5 years (AUC of ROC curve was 0.624) or D-dimer >4.72 μg/ml (AUC of ROC curve was 0.656).Conclusion: Age < 63.5 years, male sex, proximal LEDVT, bilateral LEDVT and D-dimer >4.72 μg/ml were risk factors. The diagnostic efficiency of the predictive model for predicting IVCT was superior to that of a single risk factor alone. It may be used for predicting the probability of nonfilter-associated IVCT in patients with LEDVT.